Engineers Gate Manager LP Athenex, Inc. Transaction History

Engineers Gate Manager LP

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 May 16, 2022	SELL	$0.79 - $1.59 $12,015 - $24,182	-15,209 Closed	0 $0
Q4 2021 Feb 14, 2022	BUY	$1.36 - $2.94 $20,684 - $44,714	15,209 New	15,209 $21,000
Q1 2021 May 17, 2021	SELL	$4.08 - $14.75 $55,447 - $200,452	-13,590 Closed	0 $0
Q4 2020 Feb 16, 2021	BUY	$11.06 - $14.01 $150,305 - $190,395	13,590 New	13,590 $150,000
Q3 2020 Nov 16, 2020	SELL	$10.26 - $14.55 $176,882 - $250,842	-17,240 Closed	0 $0

Q2 2020 Aug 17, 2020	SELL	$7.11 - $13.76 $321,087 - $621,401	-45,160 Reduced 72.37%	17,240 $237,000
Q1 2020 May 15, 2020	BUY	$5.71 - $15.85 $356,304 - $989,040	62,400 New	62,400 $483,000

1.46M

Ticker ATNX
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 156,790,000
Market Cap $1.57M
Description
Athenex, Inc., a biopharmaceutical company, engages in the discovery, development, and commercialization of drugs for the treatment of cancer. It operates through three segments: Oncology Innovation Platform, Global Supply Chain Platform, and Commercial Platform. The company's Orascovery product candidates include Oral paclitaxel and encequidar,...

Get notified when there are updates to the investment portfolio of Engineers Gate Manager LP, based on Form 13F filings with the SEC.

Stay updated on Engineers Gate Manager LP with notifications on news.